In comparison of PBK to FECD cases, there were no relevant differences regarding the expression pattern of aggrecan, while significantly stronger immunoreactivity was present in PBK and FECD cases as compared to normal corneas. This evidence concerns the gene ACAN and Fuchs endothelial corneal dystrophy.